Raptor Pharmaceuticals

Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Shire PLC (ADR) May Now Seek Rare Disease Expansion With Raptor Pharmaceutical Corp.
Bidness, ETC
Shire
Raptor Pharmaceuticals
M&A
Retrophin
Rare Diseases
Flag link:
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Raptor Soars After Retrophin Said to Consider Bid for Drugmaker
Bloomberg
Raptor Pharmaceuticals
Retrophin
Martin Shkreli
Flag link:
4 Key Biopharma Movers of the Past Week
4 Key Biopharma Movers of the Past Week
24/7 Wall St
Relypsa
Valeant Pharmaceuticals
Celator Pharmaceuticals
Raptor Pharmaceuticals
Flag link:
U.S. drug developer Raptor Pharmaceuticals explores sale -sources
U.S. drug developer Raptor Pharmaceuticals explores sale -sources
Yahoo/Reuters
Raptor Pharmaceuticals
M&A
Flag link:
Top 6 Biotech Movers From The Past Week
Top 6 Biotech Movers From The Past Week
24/7 Wall St
Aerie Pharma
Can-Fite BioPharma
Intra-Cellular Therapies
Raptor Pharmaceuticals
TRACON Pharmaceuticals
XenoPort
Flag link:
Raptor buys into cystic fibrosis with a $418M deal
Raptor buys into cystic fibrosis with a $418M deal
Fierce Biotech
Raptor Pharmaceuticals
cystic fibrosis
Quinsair
Tripex
Flag link:
Big Downside Ahead for Raptor?
Big Downside Ahead for Raptor?
24/7 Wall St
Raptor Pharmaceuticals
procysbi
Flag link:
After hep C cure, companies target next big liver disease market
After hep C cure, companies target next big liver disease market
Yahoo/Reuters
hepatitis B
hepatitis
nonalcoholic steatohepatitis
Gilead
Galmed Pharmaceuticals
Raptor Pharmaceuticals
Conatus Pharmaceuticals
Flag link:
Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Raptor Announces Clinical Results With RP103 in Huntington's Disease Phase 2/3 Trial
Yahoo/Benzinga
Raptor Pharmaceuticals
RP103
Huntington's disease
Flag link:
Insiders Are Selling Raptor Pharmaceuticals
Insiders Are Selling Raptor Pharmaceuticals
Seeking Alpha
Raptor Pharmaceuticals
Flag link:
Have These 4 Biotechs Peaked?
Have These 4 Biotechs Peaked?
Motley Fool
biotech
Alexion
Pharmacyclics
Aegerion
Raptor Pharmaceuticals
Flag link:
Raptor's Procysbi approved for rare disease in EU
Raptor's Procysbi approved for rare disease in EU
PharmaTimes
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Flag link:
Will You Adopt This Orphan Drug?
Will You Adopt This Orphan Drug?
Motley Fool
nephropathic cystinosis
Raptor Pharmaceuticals
procysbi
Flag link:
Raptor Pharmaceutical Corporation: A Dose Of Reality For Investors
Raptor Pharmaceutical Corporation: A Dose Of Reality For Investors
Seeking Alpha
Raptor Pharmaceuticals
Flag link:
Raptor receives positive orphan drug opinion from EU committee
Raptor receives positive orphan drug opinion from EU committee
Yahoo/Fly on the Wall
Raptor Pharmaceuticals
Europe
procysbi
Flag link:
5 Speculative Biotech Stocks With Catalysts Pending: Revisited
5 Speculative Biotech Stocks With Catalysts Pending: Revisited
Seeking Alpha
NewLink Genetics
OncoSec Medical
Arqule
Raptor Pharmaceuticals
Zogenix
Flag link:
US Exclusivity for Raptor's Procysbi
US Exclusivity for Raptor's Procysbi
Yahoo/Zacks
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
orphan drugs
Flag link:
Raptor Pharma's Procysbi Launched in the US
Raptor Pharma's Procysbi Launched in the US
Yahoo/Zacks
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Flag link:
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
US FDA approves Raptor Pharma's Procysbi for treatment of nephropathic cystinosis
Pharmabiz
Raptor Pharmaceuticals
procysbi
nephropathic cystinosis
Flag link:
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
Raptor's FDA Approval Is New Test For Orphan Drug Pricing
TheStreet.com
FDA
Raptor Pharmaceuticals
orphan drugs
procysbi
nephropathic cystinosis
Flag link:

Pages